Co-Diagnostics, Inc.
CODX- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001692415
No open-market purchases or sales by Co-Diagnostics, Inc. insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $1.85M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Co-Diagnostics, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 55 | 2 | 45 | −8 |
| Shares | 5.38M | 27.3K | 4.44M | −917.3K (−17.1%) |
| Value | $8.06M | $58.6K | $4.93M | −$3.08M (−38.4%) |
2 institutions that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held Co-Diagnostics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Portside Wealth Group, LLC | 12,000 | $13.3K | 0.00% |
| Federated Hermes, Inc. | 2,731 | $3.03K | 0.00% |
| First Horizon Advisors, Inc. | 1,400 | $1.55K | 0.00% |
| Rhumbline Advisers | 972 | $1.08K | 0.00% |
| Royal Bank of Canada | 431 | $0 | 0.00% |
Sold out (13)
Institutions that held Co-Diagnostics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Cambridge Investment Research Advisors, Inc. | 54,866 | $81.0K |
| Jacobs Levy Equity Management, Inc | 49,271 | $72.9K |
| Hussman Strategic Advisors, Inc. | 36,000 | $53.3K |
| Virtu Financial LLC | 15,743 | $23.0K |
| Jane Street Group, LLC | 14,848 | $22.0K |
| HRT Financial LP | 12,517 | $18.0K |
| Charles Schwab Investment Management Inc | 11,070 | $16.4K |
| Victory Capital Management Inc | 10,667 | $15.8K |
| Squarepoint Ops LLC | 10,590 | $15.7K |
| Dark Forest Capital Management LP | 4,284 | $6.34K |
| Belpointe Asset Management LLC | 509 | $753 |
| Northwestern Mutual Wealth Management Co | 1 | $1 |
| Simplex Trading, LLC | 117 | $0 |
Not filed for Q2 2023 yet (2)
Institutions that held Co-Diagnostics, Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| SMI Advisory Services, LLC | 17,499 | $44.1K |
| ETF Managers Group, LLC | 9,819 | $14.5K |